| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STANDER DEON | President & CEO, Director | 8080 NORTON PARKWAY, MENTOR | /s/ Vikas Arora, attorney-in-fact for Deon Stander | 03 Mar 2026 | 0001681362 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | Options Exercise | $355,279 | +1,824 | +2.8% | $194.78 | 66,968 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $105,960 | -544 | -0.81% | $194.78 | 66,424 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $269,186 | +1,382 | +2.1% | $194.78 | 67,806 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $80,249 | -412 | -0.61% | $194.78 | 67,394 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $590,768 | +3,033 | +4.5% | $194.78 | 70,427 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $223,218 | -1,146 | -1.6% | $194.78 | 69,281 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $945,462 | +4,854 | +7% | $194.78 | 74,135 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $461,629 | -2,370 | -3.2% | $194.78 | 71,765 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $603,818 | +3,100 | +4.3% | $194.78 | 74,865 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $294,897 | -1,514 | -2% | $194.78 | 73,351 | 01 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2026 RSU Award | Award | $0 | +16,622 | $0.000000 | 16,622 | 01 Mar 2026 | Common Stock | 16,622 | $0.000000 | Direct | F1 | |
| transaction | AVY | 2026 PU Award | Award | $0 | +24,033 | $0.000000 | 24,033 | 01 Mar 2026 | Common Stock | 24,033 | $0.000000 | Direct | F2 | |
| transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -1,824 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 1,824 | $0.000000 | Direct | F3 |
| transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -1,382 | -50% | $0.000000 | 1,364 | 01 Mar 2026 | Common Stock | 1,382 | $0.000000 | Direct | F4 |
| transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -3,033 | -32% | $0.000000 | 6,353 | 01 Mar 2026 | Common Stock | 3,033 | $0.000000 | Direct | F5 |
| transaction | AVY | 2025 MSU Award | Options Exercise | $0 | -4,854 | -24% | $0.000000 | 15,170 | 01 Mar 2026 | Common Stock | 4,854 | $0.000000 | Direct | F6 |
| transaction | AVY | 2023 PU Award | Options Exercise | $0 | -3,100 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 3,100 | $0.000000 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| F2 | Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock. |
| F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period. |
| F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period. |
| F7 | Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target. |